Exploring : Actualité Exploring en direct - P1 | Bourse Reflex
Accueil > Tags > Exploring

  • Toutes les actualités en rapport avec « Exploring »

19/04 17:45 Exploring - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

09/04 18:00 Exploring - Quantum Genomics strengthens its governance

29/03 18:00 Exploring - Quantum Genomics publishes its financial results for the year 2017

05/03 18:30 Exploring - Quantum Genomics Secures Operational Flexibility and Growth Capital through Equity Line Financing with Kepler Cheuvreux

29/12 14:30 Exploring - Quantum Genomics to Present at Biotech Showcase 2018

15/11 07:30 Exploring - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

27/10 07:30 Exploring - Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

16/10 18:00 Exploring - Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

03/10 18:15 Exploring - Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

06/04 12:00 Exploring - 2015 results, commercialization milestones and strategic roadmap

17/02 18:00 Exploring - 2015 results: net income of EUR32.6 million, up 30%

14/12 11:00 Exploring - ELECTRO POWER SYSTEMS BRINGS THE SPIRIT OF SILICON VALLEY TO ITALY

03/06 07:00 Exploring - Le PDG d'Addex Pharmaceuticals quitte ses fonctions

13/05 18:30 Exploring - Q1-2011 Sales information

28/04 18:00 Exploring - Les actionnaires d'Addex nomment Hoyoung Huh et Oleg Nodelman au Conseil d'Administration et approuvent toutes les propositions lors de l'Assemblée Générale Annuelle 2011

01/04 13:30 Exploring - NASDAQ OMX Group Inc. and IntercontinentalExchange Propose Superior Transaction to Acquire NYSE Euronext for USD 42.50 Per Share, 19% Premium to Deutsche Boerse Proposal

31/03 07:01 Exploring - Addex lance l'essai clinique de Phase IIa du Dipraglurant-IR pour le traitement de la dyskinésie induite par la L-dopa dans la maladie de Parkinson (MP-DIL)

28/03 07:01 Exploring - Le partenaire d'Addex commence les essais cliniques dans la schizophrénie

14/03 07:01 Exploring - Conversion des Bons Convertibles en Actions par Emission d'Actions Ordinaires

23/02 07:01 Exploring - Résultats financiers 2010 d'Addex Pharmaceuticals